The Westminster lensArchive · Written questions · 122 tabled · 107 answered

Written questions by Qureshi.

Every parliamentary written question tabled by Yasmin Qureshi this session, with the full answer and department. See how every department answers, or back to the MP page.

Department:All (122)Department of Health and Social Care (51)Department for Environment, Food and Rural Affairs (10)Department for Education (10)Home Office (8)Foreign, Commonwealth and Development Office (7)Department for Transport (5)Department for Work and Pensions (5)Ministry of Housing, Communities and Local Government (4)Ministry of Justice (4)Department for Business and Trade (4)Cabinet Office (3)Ministry of Defence (3)

Showing 4151 of 51 · Department of Health and Social Care

← PreviousPage 3 of 3
2 Sept 2024·Department of Health and Social Care·Answered
Asked

Whether (a) it remains his policy to double the number of cancer scanners in the NHS and (b) that includes doubling the number of positron emission tomography scanners.

Reply

We are working towards our commitment of doubling cancer scanners to address the challenges in diagnostic waiting times. Our commitment is related to magnetic resonance imaging and computed tomography (CT) but of course we are also considering what increa...

2 Sept 2024·Department of Health and Social Care·Answered
Asked

With reference to the decision by the Medicines and Healthcare products Regulatory Agency on 22 August 2024 to licence lecanemab for patients with early stage Alzheimer's disease, what discussions

Reply

Department officials have had a number of conversations with colleagues in NHS England about their plans to support the adoption of any licensed and National Institute for Health and Care Excellence (NICE) recommended treatment for Alzheimer’s disease.The...

30 Aug 2024·Department of Health and Social Care·Answered
Asked

What assessment he has made of the potential merits of adding medications for (a) chronic kidney disease and (b) recipients of kidney transplants to the NHS prescription charge exemption list.

Reply

There are no current plans to review the list of medical conditions that entitle someone to apply for a medical exemption certificate. Approximately 89% of prescription items are dispensed free of charge in the community in England, and there are a wide range of exemptions from prescription charges already in place for which those with chronic kidney disease or in receipt of a kidney transplant may be eligible. Eligibility depends on the patient’s age, whether they are in qualifying full-time education, whether they are pregnant or have recently given birth, or whether they are in receipt of certain benefits or a war pension.People on low incomes can apply for help with their health costs through the NHS Low Income Scheme. Prescription prepayment certificates (PPCs) are also available. PPCs allow people to claim as many prescriptions as they need for a set cost, with three month and 12-month certificates available. The 12-month PPC can be paid for in instalments.

30 Jul 2024·Department of Health and Social Care·Answered
Asked

What assessment he has made of the adequacy of the regulation of sales of weight loss injections by online pharmacies.

Reply

When used appropriately, online prescribing provides a valuable route for patient access, taking pressure off general practices. We are concerned, however, about some online prescribing, including the prescribing of weight loss medicines by online businesses. These are prescription only medicines (POMs), licensed for use in the United Kingdom by the Medicines and Healthcare products Regulatory Agency (MHRA), and should be prescribed according to the terms of the MHRA’s marketing authorisation. Prescribing outside of these terms, known as off-label prescribing, should only take place when the prescriber doing so judges it to be in the best interest of the patient, on the basis of the available evidence.Rules regarding the advertising and promotion of medicines in the UK are set out under Part 14 of the Human Medicines Regulations 2012. The MHRA works closely with other regulators to help ensure that the public is protected from the advertising of POMs. A joint enforcement operation is in place with the Advertising Standards Authority to take targeted action against weight-loss treatment providers who use social media to promote POMs. In England, online prescribing is regulated by the Care Quality Commission and the General Pharmaceutical Council (GPhC). The GPhC regulates the supply of medicines against prescriptions in pharmacies. Regulators are able to take action when a provider does not comply with the standards.

30 Jul 2024·Department of Health and Social Care·Answered
Asked

If he will make an assessment of the adequacy of funding for the planned extension of Dental Foundation Training places after 2031.

Reply

The NHS Long Term Workforce Plan has made up to £2.4 billion available to support the additional education and training expansion across the plan up to 2028/29. This settlement pre-empted the next spending review. Revenue funding for the increase of undergraduate dental training places up to 2028/29 is provided within this. Decisions about funding beyond 2028/29, will be considered at a later date.

30 Jul 2024·Department of Health and Social Care·Answered
Asked

Whether the plans to increase dental training places by 40% by 2031-32 outlined in the NHS Long Term Workforce Plan are fully funded.

Reply

The NHS Long Term Workforce Plan has made up to £2.4 billion available to support the additional education and training expansion across the plan up to 2028/29. This settlement pre-empted the next spending review. Revenue funding for the increase of undergraduate dental training places up to 2028/29 is provided within this. Decisions about funding beyond 2028/29, will be considered at a later date.

30 Jul 2024·Department of Health and Social Care·Answered
Asked

What steps his Department is taking to support those impacted by Primodos.

Reply

Primodos is one of three areas Baroness Cumberlege was asked to look into as part of her Independent Medicines and Medical Devices Review, which reported in 2020. Since the report was published, action has been taken to address the issues identified, including appointing the first Patient Safety Commissioner to champion patient voice in relation to the safety of medicines and medical devices.

30 Jul 2024·Department of Health and Social Care·Answered
Asked

Whether the plans to increase dental training places by 40% by 2031-32 outlined in the NHS Long Term Workforce Plan are fully funded.

Reply

The NHS Long Term Workforce Plan has made up to £2.4 billion available to support the additional education and training expansion across the plan up to 2028/29. This settlement pre-empted the next spending review. Revenue funding for the increase of undergraduate dental training places up to 2028/29 is provided within this. Decisions about funding beyond 2028/29, will be considered at a later date.

30 Jul 2024·Department of Health and Social Care·Answered
Asked

How much capital funding he plans to provide to expand dental school estates to accommodate the increased number of dental students from September 2026.

Reply

The Department for Education is responsible for capital investment in Higher Education Institutions, including dental schools, and we will work closely with them on this matter. Specific programmes of capital funding to support dental school expansion are subject to the upcoming spending review.

30 Jul 2024·Department of Health and Social Care·Answered
Asked

Whether the cost of training for new dental academic staff to support the expansion of dental school places in the NHS Long Term Workforce Plan is fully funded.

Reply

Higher Education Institutions are responsible for training their members of staff, and ensuring they have adequate staffing levels to teach their courses.

30 Jul 2024·Department of Health and Social Care·Answered
Asked

If he will commission an independent review of the Report of the Commission on Human Medicines’ Expert Working Group on Hormone Pregnancy Tests, published on 15 November 2017.

Reply

We are hugely sympathetic to the families who believe that they or their children have suffered following the use of hormone pregnancy tests. It is not currently the Government’s intention to review the Report of the Commission on Human Medicines; however we are committed to reviewing any new scientific evidence which may come to light.

← PreviousPage 3 of 3
Sources
SourceUK Parliament Members API
MethodQuestion and answer text as published. Question preamble (“To ask the…”) trimmed for readability; answers shown in full.